Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Clinical genetics in 2014

New monogenic diseases span the immunological disease continuum

Three monogenic diseases, with features of both autoinflammation and autoimmunity, were described for the first time in 2014. As well as providing insights into the molecular basis of several rare immunological disorders, the discoveries have implications for their diagnosis and treatment.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Autoinflammatory and autoimmune features of three new monogenic diseases.

References

  1. McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006).

    Article  Google Scholar 

  2. Zhou, Q. et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N. Engl. J. Med. 370, 911–920 (2014).

    Article  CAS  Google Scholar 

  3. Rice, G. I. et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46, 503–509 (2014).

    Article  CAS  Google Scholar 

  4. Kuehn, H. S. et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345, 1623–1627 (2014).

    Article  CAS  Google Scholar 

  5. Kastner, D. L., Zhou, Q. & Aksentijevich, I. Mutant ADA2 in vasculopathies. N. Engl. J. Med. 371, 480–481 (2014).

    CAS  PubMed  Google Scholar 

  6. Crow, Y. J. Type I interferonopathies: Mendelian type I interferon up-regulation. Curr. Opin. Immunol. 32, 7–12 (2015).

    Article  CAS  Google Scholar 

  7. Romo-Tena, J. Gómez-Martín, D. & Alcocer-Varela, J. CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance. Autoimmun. Rev. 12, 1171–1176 (2013).

    Article  CAS  Google Scholar 

  8. Walker, L. S. TREG and CTLA-4: two intertwining pathways to immune tolerance. J. Autoimmun. 45, 49–57 (2013).

    Article  CAS  Google Scholar 

  9. Rieux-Laucat, F. & Casanova, J.-L. Immunology: autoimmunity by haploinsufficiency. Science 345, 1560–1561 (2014).

    Article  CAS  Google Scholar 

  10. Schuster I. S. et al. TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity. Immunity 41, 646–656 (2014).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors' work is supported by NIHR-LMBRU. The authors apologise to colleagues whose work could not be cited because of space constraints.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael F. McDermott.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Savic, S., McDermott, M. New monogenic diseases span the immunological disease continuum. Nat Rev Rheumatol 11, 67–68 (2015). https://doi.org/10.1038/nrrheum.2014.215

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2014.215

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing